TELMISARTAN AND AMLODIPINE vs TELMISARTAN AND HYDROCHLOROTHIAZIDE

Compare TELMISARTAN AND AMLODIPINE (Telmisartan and Amlodipine) and TELMISARTAN AND HYDROCHLOROTHIAZIDE (telmisartan and hydrochlorothiazide) — clinical data, side effects, and patient experiences.

TELMISARTAN AND AMLODIPINE

Telmisartan and Amlodipine · ARB

How it works

12.1 Mechanism of Action Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the ...

Approved for

1 INDICATIONS AND USAGE Telmisartan and amlodipine tablets are indicated for the treatment of hypertension

alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

TELMISARTAN AND HYDROCHLOROTHIAZIDE

telmisartan and hydrochlorothiazide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

TELMISARTAN AND AMLODIPINETELMISARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TELMISARTAN AND AMLODIPINE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

TELMISARTAN AND AMLODIPINE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Pregnancy Category D Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk

TELMISARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on telmisartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for TELMISARTAN AND AMLODIPINE vs TELMISARTAN AND HYDROCHLOROTHIAZIDE.

TELMISARTAN AND AMLODIPINE vs TELMISARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Both TELMISARTAN AND AMLODIPINE and TELMISARTAN AND HYDROCHLOROTHIAZIDE belong to the ARB class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Shared Indications

Both medications are approved for including, as appropriate, lipid control, diabetes management. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

TELMISARTAN AND AMLODIPINE carries 4 FDA warnings. TELMISARTAN AND HYDROCHLOROTHIAZIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE→SACUBITRIL AND VALSARTAN vs TELMISARTAN AND AMLODIPINE→TELMISARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN→TELMISARTAN AND AMLODIPINE vs VALSARTAN→IRBESARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE→IRBESARTAN vs TELMISARTAN AND AMLODIPINE→

Loading comparison data...

TELMISARTAN AND AMLODIPINE vs TELMISARTAN AND HYDROCHLOROTHIAZIDE

Compare TELMISARTAN AND AMLODIPINE (Telmisartan and Amlodipine) and TELMISARTAN AND HYDROCHLOROTHIAZIDE (telmisartan and hydrochlorothiazide) — clinical data, side effects, and patient experiences.

TELMISARTAN AND AMLODIPINE

Telmisartan and Amlodipine · ARB

How it works

12.1 Mechanism of Action Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the ...

Approved for

1 INDICATIONS AND USAGE Telmisartan and amlodipine tablets are indicated for the treatment of hypertension

alone or with other antihypertensive agents to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

TELMISARTAN AND HYDROCHLOROTHIAZIDE

telmisartan and hydrochlorothiazide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

TELMISARTAN AND AMLODIPINETELMISARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TELMISARTAN AND AMLODIPINE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

TELMISARTAN AND AMLODIPINE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Pregnancy Category D Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk

TELMISARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on telmisartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for TELMISARTAN AND AMLODIPINE vs TELMISARTAN AND HYDROCHLOROTHIAZIDE.

TELMISARTAN AND AMLODIPINE vs TELMISARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Shared Indications

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.